CAPE attenuates proliferation, invasion, and growth of bladder carcinoma cells in vitro and in vivo, inducing the expressions of GDF15, NDRG1, and maspin via ERK, p38, or AMPKα1/2 signaling pathways. Here, PRKAA1 is linked to urinary bladder carcinoma.